Discover
TRAW
Traws Pharma, Inc.
0.49
2 x 0.38
2 x 0.71
bid
ask
-
0.05
8.50%
2 @ 07:30 PM
0.50 +0.01 (2.00%)
| Ytd | -56.64% | |
| 1y | -76.21% |
0.48
day range
0.54
0.44
52 week range
3.13
| Open | 0.54 | Prev Close | 0.54 | Low | 0.48 | High | 0.54 | Mkt Cap | 7.53M |
| Vol | 193.79K | Avg Vol | 123.65K | EPS | -1.83 | P/E | N/A | Forward P/E | -0.47 |
| Beta | 1.41 | Short Ratio | 0.62 | Inst. Own | 21.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.56 | 200-d Avg | 1.35 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 3.18M | ||
| Research and Development Expense | 1.10M | ||
| Selling, General and Administrative Expense | 3.48M | ||
| Operating Income | -3.17M | ||
| Net Income | -2.61M | ||
| Net Income Common Stock | -2.61M | ||
| Net Income Common Stock (USD) | -2.61M | ||
| Consolidated Income | -3.05M | ||
| Net Income to Non-Controlling Interests | -443.00K | ||
| Earnings per Basic Share | -0.16 | ||
| Earnings per Basic Share (USD) | -0.16 | ||
| Earnings per Diluted Share | -0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -2.61M | ||
| Earning Before Interest & Taxes (USD) | -2.61M | ||
| Weighted Average Shares | 15.86M | ||
| Weighted Average Shares Diluted | 15.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.02M | ||
| Cash and Equivalents (USD) | 5.02M | ||
| Current Assets | 9.02M | ||
| Property, Plant & Equipment Net | 5.00K | ||
| Total Assets | 11.47M | ||
| Current Liabilities | 9.74M | ||
| Total Liabilities | 9.78M | ||
| Accumulated Retained Earnings (Deficit) | -650.14M | ||
| Accumulated Other Comprehensive Income | -5.00K | ||
| Shareholders Equity | 1.69M | ||
| Shareholders Equity (USD) | 1.69M | ||
| Assets Non-Current | 2.45M | ||
| Goodwill and Intangible Assets | 2.44M | ||
| Liabilities Non-Current | 44.00K | ||
| Trade and Non-Trade Payables | 6.33M | ||
| Tax Assets | 3.45M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 44.00K | ||
| Net Cash Flow from Financing | 9.39M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.88M | ||
| Issuance (Purchase) of Equity Shares | 10.12M | ||
| Net Cash Flow from Operations | -7.50M | ||
| Effect of Exchange Rate Changes on Cash | -3.00K | ||
| Share Based Compensation | 816.00K | ||